The Medical Letter on Drugs and Therapeutics
FROM
ISSUE
1481
Transdermal Fentanyl (Ionsys) for Postoperative Pain
Subscribers: Log in to read full article.  Not a subscriber?  Subscribe or purchase article.

A patient-controlled fentanyl iontophoretic transdermal system (Ionsys – The Medicines Company) is now available for short-term management of acute postoperative pain in adults requiring opioid analgesia in the hospital. Before using Ionsys, patients must be titrated to a comfortable level of analgesia with another opioid formulation.

THE DEVICE — The fentanyl iontophoretic transdermal system (ITS) has two parts: a drug unit and a controller containing the battery and electronics. The single-use, disposable device, which is about the size of a credit card, is attached to the patient's skin by an adhesive strip. A button on the controller activates a low-intensity electric current that drives a fixed dose of fentanyl ions from a hydrogel reservoir through the skin and into the systemic circulation.

PHARMACOKINETICS – The pharmacokinetic profile of transdermal fentanyl ... more      

The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.

Would you like to read the rest of this article?  Gain access below.

Subscribe
Subscriptions to The Medical Letter on Drugs and Therapeutics include:
  • Print version published and mailed biweekly (26 issues/year)
  • Unlimited online access to current and past issues (1988 - present)
  • Mobile App for iOS, Android, and Kindle Fire
  • FREE online per issue CME/CE
Purchase this article:
Title: Transdermal Fentanyl (Ionsys) for Postoperative Pain
Article code: 1481d
 Electronic, downloadable article - $45
Gain access through your organization
Ask your librarian to consider an Institutional Subscription to The Medical Letter.
Recommend to your librarian